Literature DB >> 29339357

Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma.

Michelle L Baglia1, Mei-Tzu C Tang2, Kathleen E Malone2, Peggy Porter2, Christopher I Li2.   

Abstract

Background: Incidence rates of in situ breast carcinomas have increased due to widespread adoption of mammography. Very little is known about why some women with in situ breast cancer later develop second primary breast cancers.
Methods: In this population-based nested case-control study among in situ breast cancer survivors, including 539 cases with a second primary breast cancer and 994 matched controls, we evaluated the association between first-degree family history of breast cancer and risk of developing a second primary breast cancer.
Results: First-degree family history of breast cancer was associated with an increased risk of developing a second primary breast cancer among women with a previous in situ breast cancer [odds ratio (OR) = 1.33, 95% confidence interval (CI), 1.05-1.69] and those with two or more affected first-degree relatives had an even higher risk (OR = 1.94; 95% CI, 1.15-3.28). Those whose relative was diagnosed at less than 50 years old were more likely to develop a second primary breast cancer (OR = 1.78; 95% CI, 1.24-2.57). No difference in risks associated with number or age of affected relatives was observed by menopausal status.Conclusions: Results from this study suggest that first-degree family history of breast cancer may be an important risk factor for development of a second primary breast cancer among women with a previous in situ breast cancer.Impact: Given the growing population of in situ breast cancer survivors, a better understanding of risk factors associated with development of a second primary breast cancer is needed to further understand risk. Cancer Epidemiol Biomarkers Prev; 27(3); 315-20. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 29339357      PMCID: PMC5835196          DOI: 10.1158/1055-9965.EPI-17-0837

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.

Authors:  F Wärnberg; J Bergh; M Zack; L Holmberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

2.  Risk of second breast cancer according to estrogen receptor status and family history.

Authors:  Christine Bouchardy; Simone Benhamou; Gérald Fioretta; Helena M Verkooijen; Pierre O Chappuis; Isabelle Neyroud-Caspar; Monica Castiglione; Vincent Vinh-Hung; Georges Vlastos; Elisabetta Rapiti
Journal:  Breast Cancer Res Treat       Date:  2010-09-29       Impact factor: 4.872

3.  Clinical dilemma of ductal carcinoma in situ.

Authors:  Jay R Harris; Monica Morrow
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

4.  Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study.

Authors:  Elham Kharazmi; Tianhui Chen; Steven Narod; Kristina Sundquist; Kari Hemminki
Journal:  Breast Cancer Res Treat       Date:  2014-02-01       Impact factor: 4.872

5.  Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.

Authors:  Christopher I Li; Janet R Daling; Kathleen E Malone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

6.  Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications.

Authors:  William F Anderson; Kenneth C Chu; Susan S Devesa
Journal:  Breast Cancer Res Treat       Date:  2004-11       Impact factor: 4.872

Review 7.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

Authors: 
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

8.  Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.

Authors:  Elizabeth B Claus; Meredith Stowe; Darryl Carter
Journal:  Breast Cancer Res Treat       Date:  2003-03       Impact factor: 4.872

9.  Increased risk of second malignancies after in situ breast carcinoma in a population-based registry.

Authors:  I Soerjomataram; W J Louwman; M J C van der Sangen; R M H Roumen; J W W Coebergh
Journal:  Br J Cancer       Date:  2006-06-27       Impact factor: 7.640

10.  Genetic predisposition to ductal carcinoma in situ of the breast.

Authors:  Christos Petridis; Mark N Brook; Vandna Shah; Kelly Kohut; Patricia Gorman; Michele Caneppele; Dina Levi; Efterpi Papouli; Nick Orr; Angela Cox; Simon S Cross; Isabel Dos-Santos-Silva; Julian Peto; Anthony Swerdlow; Minouk J Schoemaker; Manjeet K Bolla; Qin Wang; Joe Dennis; Kyriaki Michailidou; Javier Benitez; Anna González-Neira; Daniel C Tessier; Daniel Vincent; Jingmei Li; Jonine Figueroa; Vessela Kristensen; Anne-Lise Borresen-Dale; Penny Soucy; Jacques Simard; Roger L Milne; Graham G Giles; Sara Margolin; Annika Lindblom; Thomas Brüning; Hiltrud Brauch; Melissa C Southey; John L Hopper; Thilo Dörk; Natalia V Bogdanova; Maria Kabisch; Ute Hamann; Rita K Schmutzler; Alfons Meindl; Hermann Brenner; Volker Arndt; Robert Winqvist; Katri Pylkäs; Peter A Fasching; Matthias W Beckmann; Jan Lubinski; Anna Jakubowska; Anna Marie Mulligan; Irene L Andrulis; Rob A E M Tollenaar; Peter Devilee; Loic Le Marchand; Christopher A Haiman; Arto Mannermaa; Veli-Matti Kosma; Paolo Radice; Paolo Peterlongo; Frederik Marme; Barbara Burwinkel; Carolien H M van Deurzen; Antoinette Hollestelle; Nicola Miller; Michael J Kerin; Diether Lambrechts; Giuseppe Floris; Jelle Wesseling; Henrik Flyger; Stig E Bojesen; Song Yao; Christine B Ambrosone; Georgia Chenevix-Trench; Thérèse Truong; Pascal Guénel; Anja Rudolph; Jenny Chang-Claude; Heli Nevanlinna; Carl Blomqvist; Kamila Czene; Judith S Brand; Janet E Olson; Fergus J Couch; Alison M Dunning; Per Hall; Douglas F Easton; Paul D P Pharoah; Sarah E Pinder; Marjanka K Schmidt; Ian Tomlinson; Rebecca Roylance; Montserrat García-Closas; Elinor J Sawyer
Journal:  Breast Cancer Res       Date:  2016-02-17       Impact factor: 6.466

View more
  2 in total

1.  Bisphosphonate Use and Breast Cancer Risk among Women with Ductal Carcinoma In Situ.

Authors:  Christopher I Li; Meghan R Flanagan; Mei-Tzu C Tang; Peggy L Porter; Kathleen E Malone
Journal:  Cancer Res       Date:  2021-03-24       Impact factor: 12.701

Review 2.  Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.

Authors:  Nahlah Makki Almansour
Journal:  Front Mol Biosci       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.